Acronym: VIP

(Toposar®, VePesid®, Etopophos®)

Testicular, bladder, prostate, lung, stomach, and uterine, cancers. Hodgkin's and non-Hodgkin's lymphoma, mycosis fungoides, Kaposi's sarcoma, Wilm's tumor, rhabdomyosarcoma, Ewing's sarcoma, neuroblastoma, brain tumors.

(Alkaban-AQ®, Velban®, Vinblastine Sulfate, Vincaleukoblastine, VLB)

This drug is given to treat Hodgkin's disease, non-Hodgkin's lymphoma, testicular, breast, lung, head and neck, and bladder cancers, Kaposi's sarcoma, mycosis fungoides (t-cell lymphoma), and choriocarcinoma.

It is also used in the treatment of certain blood disorders such as histiocytosis and idiopathic thrombocytopenia purpura (ITP).

(Ifex®)

Ifosfamide is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as an "alkylating agent."

Ifosfamide is give through an infusion into a vein (intravenous, IV).

The amount of ifosfamide that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition being treated. Your doctor will determine your dose and schedule.

(Platinol®, Platinol®-AQ, CDDP)

Used to treat testicular, ovarian, bladder, head and neck, esophageal, small and non-small cell lung, breast, cervical, stomach and prostate cancers. Also to treat Hodgkin's and non-Hodgkin's lymphomas, neuroblastoma, sarcomas, multiple myeloma, melanoma, and mesothelioma.

(Mesnex)

Prevention of ifosfamide-induced hemorrhagic cystitis (syndrome of bleeding and irritation of the bladder).

Prevention of high-dose cyclophosphamide-induced hemorrhagic cystitis.